Prevymis (letermovir) - Merck (MSD)
The Impact of Cytomegalovirus Reactivation on Cytomegalovirus-Specific Immune Reconstitution in Hematopoietic Stem Cell Transplant Recipients Receiving Letermovir Prophylaxis. (PubMed, Open Forum Infect Dis) - Apr 1, 2026 - "Cytomegalovirus-specific immune reconstitution appears delayed in DSD compared with DRD patients, potentially reflecting limited exposure to replication-competent virus. Assessment of CMV-specific T-cell polyfunctionality may help identify HSCT recipients at increased risk for late CMV reactivation." 
Journal • Acute Graft versus Host Disease • Bone Marrow Transplantation • Cytomegalovirus Infection • Graft versus Host Disease • Immunology • Infectious Disease • Transplantation • CD4 • CD8
http://www.ncbi.nlm.nih.gov/pubmed/41918957
 
Cen Jiang; Gang Cai; Lilan Jin; Luxiang Wang; Xiaoxia Hu; Yanying Gu
 
Apr 1, 2026
 
Prev Next